| Activation of AMP‐activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders B Viollet, M Foretz, B Guigas, S Horman, R Dentin, L Bertrand, L Hue, ... The Journal of physiology 574 (1), 41-53, 2006 | 650 | 2006 |
| A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange Y Liu, R Dentin, D Chen, S Hedrick, K Ravnskjaer, S Schenk, J Milne, ... Nature 456 (7219), 269-273, 2008 | 633 | 2008 |
| Cryptochrome mediates circadian regulation of cAMP signaling and hepatic gluconeogenesis EE Zhang, Y Liu, R Dentin, PY Pongsawakul, AC Liu, T Hirota, ... Nature medicine 16 (10), 1152-1156, 2010 | 623 | 2010 |
| Role of the liver in the control of carbohydrate and lipid homeostasis C Postic, R Dentin, J Girard Diabetes & metabolism 30 (5), 398-408, 2004 | 564 | 2004 |
| Liver-Specific Inhibition of ChREBP Improves Hepatic Steatosis and Insulin Resistance in ob/ob Mice R Dentin, F Benhamed, I Hainault, V Fauveau, F Foufelle, JRB Dyck, ... Diabetes 55 (8), 2159-2170, 2006 | 530 | 2006 |
| Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression R Dentin, JP Pégorier, F Benhamed, F Foufelle, P Ferré, V Fauveau, ... Journal of Biological Chemistry 279 (19), 20314-20326, 2004 | 526 | 2004 |
| Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2 R Dentin, Y Liu, SH Koo, S Hedrick, T Vargas, J Heredia, J Yates III, ... Nature 449 (7160), 366-369, 2007 | 484 | 2007 |
| Carbohydrate responsive element binding protein (ChREBP) and sterol regulatory element binding protein-1c (SREBP-1c): two key regulators of glucose metabolism and lipid … R Dentin, J Girard, C Postic Biochimie 87 (1), 81-86, 2005 | 422 | 2005 |
| Polyunsaturated fatty acids suppress glycolytic and lipogenic genes through the inhibition of ChREBP nuclear protein translocation R Dentin, F Benhamed, JP Pégorier, F Foufelle, B Viollet, S Vaulont, ... The Journal of clinical investigation 115 (10), 2843-2854, 2005 | 396 | 2005 |
| Hepatic glucose sensing via the CREB coactivator CRTC2 R Dentin, S Hedrick, J Xie, J Yates III, M Montminy Science 319 (5868), 1402-1405, 2008 | 384 | 2008 |
| Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice J Bricambert, J Miranda, F Benhamed, J Girard, C Postic, R Dentin The Journal of clinical investigation 120 (12), 4316-4331, 2010 | 331 | 2010 |
| ChREBP, a transcriptional regulator of glucose and lipid metabolism C Postic, R Dentin, PD Denechaud, J Girard Annu. Rev. Nutr. 27, 179-192, 2007 | 310 | 2007 |
| Adipocyte CREB promotes insulin resistance in obesity L Qi, M Saberi, E Zmuda, Y Wang, J Altarejos, X Zhang, R Dentin, ... Cell metabolism 9 (3), 277-286, 2009 | 234 | 2009 |
| O-GlcNAcylation Increases ChREBP Protein Content and Transcriptional Activity in the Liver C Guinez, G Filhoulaud, F Rayah-Benhamed, S Marmier, C Dubuquoy, ... Diabetes 60 (5), 1399-1413, 2011 | 229 | 2011 |
| Novel insights into ChREBP regulation and function G Filhoulaud, S Guilmeau, R Dentin, J Girard, C Postic Trends in Endocrinology & Metabolism 24 (5), 257-268, 2013 | 227 | 2013 |
| Role of ChREBP in hepatic steatosis and insulin resistance PD Denechaud, R Dentin, J Girard, C Postic FEBS letters 582 (1), 68-73, 2008 | 198 | 2008 |
| Glucose 6-phosphate, rather than xylulose 5-phosphate, is required for the activation of ChREBP in response to glucose in the liver R Dentin, L Tomas-Cobos, F Foufelle, J Leopold, J Girard, C Postic, ... Journal of hepatology 56 (1), 199-209, 2012 | 186 | 2012 |
| A specific ChREBP and PPARα cross-talk is required for the glucose-mediated FGF21 response A Iroz, A Montagner, F Benhamed, F Levavasseur, A Polizzi, E Anthony, ... Cell reports 21 (2), 403-416, 2017 | 123 | 2017 |
| Hepatic gene regulation by glucose and polyunsaturated fatty acids: a role for ChREBP R Dentin, PD Denechaud, F Benhamed, J Girard, C Postic The Journal of nutrition 136 (5), 1145-1149, 2006 | 107 | 2006 |
| The histone demethylase Phf2 acts as a molecular checkpoint to prevent NAFLD progression during obesity J Bricambert, MC Alves-Guerra, P Esteves, C Prip-Buus, ... Nature Communications 9 (1), 2092, 2018 | 79 | 2018 |
